Posted inBusiness
Biocon Shares Gain Following Major Block Deal Worth Rs 638 Crore
Biocon shares increased by 3 percent following a massive block deal valued at Rs 638 crore involving nearly 1.65 crore shares.
Posted inBusiness
How Veteran Investor Vijay Kedia Achieved Massive Returns on Neuland Laboratories
Discover how veteran market expert Vijay Kedia turned a modest investment in Neuland Laboratories into nearly 100x returns with strategic focus.
Posted inBusiness
Gland Pharma Shares Drop 3 Percent Following Major Block Deals
Gland Pharma shares fell 3 percent after a massive block deal involving over one crore shares. Promoter Fosun is identified as the likely seller.
